Chinese herbal medicine for the treatment of obesity-related hypertension

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Jie ^a   Feng, Bo ^a   Xiong, Xingjiang ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; BENZENESULFONIC LEVAMLODIPINE; CAPTOPRIL; CHINESE DRUG; HERBACEOUS AGENT; HUANGLIAN WENDAN; METFORMIN; MODIFIED FULING GUIZHI BAIZHU GANCAO; MODIFIED LIUJUNZI; MODIFIED WENDAN; NAOXINTONG; NITRENDIPINE; PERINDOPRIL; PINGGAN YISHEN DITAN; QINGRE HUOXUE QUTAN; SHUGAN YUNPI; TAOHONG ERCHEN TIANMA; UNCLASSIFIED DRUG;

ADVERSE DRUG REACTION; BLOOD PRESSURE MONITORING; CHINESE MEDICINE; COMPARATIVE STUDY; DATA EXTRACTION; DIASTOLIC BLOOD PRESSURE; DIET; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EXERCISE; HERBAL MEDICINE; HUMAN; HYPERTENSION; META ANALYSIS; OBESITY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84880160805     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/757540     Document Type: Review

References (57)

1. Howard K. K., Julie J. P., Shiriki K., Fielding J. E., Healthy people: a 2020 vision for the social determinants approach. Health Education and Behavior 2011 38 6 551 557 2-s2.0-81355123317 10.1177/1090198111428646
2. Flegal K. M., Carroll M. D., Ogden C. L., Curtin L. R., Prevalence and trends in obesity among US adults, 1999-2008. Journal of the American Medical Association 2010 303 3 235 241 2-s2.0-74549140993 10.1001/jama.2009.2014
3. Becton L. J., Shatat I. F., Flynn J. T., Hypertension and obesity: epidemiology, mechanisms and clinical approach. Indian Journal of Pediatrics 2012 79 8 1056 1061 10.1007/s12098-012-0777-x
4. Kurukulasuriya L. R., Stas S., Lastra G., Manrique C., Sowers J. R., Hypertension in obesity. Medical Clinics of North America 2011 95 5 903 917 2-s2.0-80051771011 10.1016/j.mcna.2011.06.004
5. Kotchen T. A., Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. American Journal of Hypertension 2010 23 11 1170 1178 2-s2.0-77958088160 10.1038/ajh.2010.172
6. Haffner S., Taegtmeyer H., Epidemic obesity and the metabolic syndrome. Circulation 2003 108 13 1541 1545 2-s2.0-0141506880 10.1161/01.CIR.0000088845. 17586.EC
7. Sarzani R., Salvi F., Dessì-Fulgheri P., Rappelli A., Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. Journal of Hypertension 2008 26 5 831 843 2-s2.0-42149112825 10.1097/HJH.0b013e3282f624a0
8. Reaven G. M., Lithell H., Landsberg L., Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. New England Journal of Medicine 1996 334 6 374 381 2-s2.0-0030025673 10.1056/NEJM199602083340607
9. Shankar A., Xiao J., Positive relationship between plasma leptin level and hypertension. Hypertension 2010 56 4 623 628 2-s2.0-77957223754 10.1161/HYPERTENSIONAHA.109.148213
10. Esler M., Straznicky N., Eikelis N., Masuo K., Lambert G., Lambert E., Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006 48 5 787 796 2-s2.0-33750281024 10.1161/01.HYP.0000242642. 42177.49
11. Reisin E., Treatment strategies for obesity-related hypertension. Current Hypertension Reports 2008 10 2 129 130 10.1007/s11906-008-0024-z
12. Nahas R., Complementary and alternative medicine approaches to blood pressure reduction: an evidence-based review. Canadian Family Physician 2008 54 11 1529 1533 2-s2.0-56549103740
13. Ernst E., Complementary/alternative medicine for hypertension: a mini-review. Wiener Medizinische Wochenschrift 2005 155 17-18 386 391 2-s2.0-26944475172 10.1007/s10354-005-0205-1
14. Vernooij J. W. P., van der Graaf Y., Visseren F. L. J., Spiering W., On Behalf of the SMART Study Group, The prevalence of obesity-related hypertension and risk for new vascular events in patients with vascular diseases. Obesity 2012 20 10 2118 2123 10.1038/oby.2012.76
15. Park H. L., Lee H. S., Shin B. C., Liu J. P., Shang Q. H., Yamashita H., Lim B., Traditional medicine in China, Korea, and Japan: a brief introduction and comparison. Evidence-Based Complementary and Alternative Medicine 2012 2012 9 429103 10.1155/2012/429103
16. Wood M. J., Stewart R. L., Merry H., Johnstone D. E., Cox J. L., Use of complementary and alternative medical therapies in patients with cardiovascular disease. American Heart Journal 2003 145 5 806 812 2-s2.0-0038404499 10.1016/S0002-8703(03)00084-X
17. Yeh G. Y., Davis R. B., Phillips R. S., Use of complementary therapies in patients with cardiovascular disease. American Journal of Cardiology 2006 98 5 673 680 2-s2.0-33747171757 10.1016/j.amjcard.2006.03.051
18. Xu H., Chen K. J., Complementary and alternative medicine: is it possible to be mainstream? Chinese Journal of Integrative Medicine 2012 18 6 403 404
19. Chen K. J., Hui K. K., Lee M. S., Xu H., The potential benefit of complementary/alternative medicine in cardiovascular diseases. Evidence-Based Complementary and Alternative Medicine 2012 2012 1 125029 10.1155/2012/125029
20. Wang J., Xiong X. J., Current situation and perspectives of clinical study in integrative medicine in China. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 268542 10.1155/2012/268542
21. Xu H., Chen K., Integrative medicine: the experience from China. Journal of Alternative and Complementary Medicine 2008 14 1 3 7 2-s2.0-38749126248 10.1089/acm.2006.6329
22. Chen K. J., Xu H., The integration of traditional Chinese medicine and Western medicine. European Review 2003 11 2 225 235 2-s2.0-0038115317 10.1017/S106279870300022X
23. Bell R. A., Suerken C. K., Grzywacz J. G., Lang W., Quandt S. A., Arcury T. A., CAM use among older adults age 65 or older with hypertension in the United States: general use and disease treatment. Journal of Alternative and Complementary Medicine 2006 12 9 903 909 2-s2.0-33751080093 10.1089/acm.2006.12. 903
24. Kaplan N. M., Acupuncture for hypertension: can 2500 years come to an end? Hypertension 2006 48 5 815 2-s2.0-33750271915 10.1161/01.HYP.0000241069. 80574.76
25. Wang J., Xiong X., Control strategy on hypertension in Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 2-s2.0-84855609561 10.1155/2012/284847 284847
26. Xiong X. J., Yang X. C., Liu Y. M., Zhang Y., Wang P. Q., Wang J., Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science. Hypertension Research 2013 10.1038/hr.2013.18
27. Xu H., Chen K., Herb-drug interaction: an emerging issue of integrative medicine. Chinese Journal of Integrative Medicine 2010 16 3 195 196 2-s2.0-78149421985 10.1007/s11655-010-0195-z
28. Xu H., Chen K., Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chinese Journal of Integrative Medicine 2011 17 2 83 84 2-s2.0-79952558248 10.1007/s11655-011-0641-2
29. Liu M. Y., Chen K. J., Convergence: the tradition and the modern. Chinese Journal of Integrative Medicine 2012 18 3 164 165 10.1007/s11655-012-1014-1
30. Tian P., Convergence: where West meets East. Nature 2011 480 7378 S84 S86 2-s2.0-84055184876 10.1038/480S84a
31. Wang J., Xiong X. J., Evidence-based Chinese medicine for hypertension. Evidence-Based Complementary and Alternative Medicine 2013 2013 12 978398 10.1155/2013/978398
32. Wang J., Feng B., Yang X. C., Liu W., Liu Y. M., Zhang Y., Yu G., Li S. J., Zhang Y. Q., Xiong X. J., Tianma gouteng yin as adjunctive treatment for essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2013 2013 18 706125 10.1155/2013/706125
33. Xiong X. J., Yang X. C., Feng B., Liu W., Duan L., Gao A., Li H. X., Ma J. Z., Du X. L., Li N., Wang P. Q., Su K. L., Chu F. Y., Zhang G. H., Li X. K., Wang J., Zhen gan xi feng decoction, a traditional Chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2013 2013 9 982380 10.1155/2013/982380
34. Wang J., Yang X. C., Feng B., Qian W. D., Fang Z. Y., Liu W., Li H. X., Li X. K., Chu F. Y., Xiong X. J., Is Yangxue Qingnao Granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension? Evidence-Based Complementary and Alternative Medicine 2013 2013 8 540613 10. 1155/2013/540613.
35. Xiong X. J., Yang X. C., Liu W., Feng B., Ma J. Z., Du X. L., Wang P. Q., Chu F. Y., Li J., Wang J., Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2012 2012 10 271462 10.1155/2012/271462
36. Wang J., Yao K. W., Yang X. C., Liu W., Feng B., Ma J. Z., Du X. L., Wang P. Q., Xiong X. J., Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 714805 10. 1155/2012/714805
37. Wang J., Xiong X. J., Yang G. Y., Zhang Y. Q., Liu Y. M., Zhang Y., Zhang Z. P., Li J., Yang X. C., Chinese herbal medicine qi ju di huang wan for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2013 2013 262685
38. Lu Y., Evaluation on the intervention effect of traditional Chinese medicine appropriate technology on obesity-related hypertension in community. Yi Xue Xin Xi 2011 24 1 174 175
39. Liu X. Q., The Study of Symptoms and Signs of Wendan Tang 2010 Nanjing, China Nanjing University of Chinese Medical
40. Piao X. H., Clinical Research of Jiangzhuo Qinggan Formula on Essential Hypertension Complicated With Metabolic Syndrome 2011 Beijing, China Beijing University of Chinese Medical
41. Zhang N., Liu J. H., Effects of oat on blood pressure in the patients of hypergravity/obesity with hypertension. Neimenggu Da Xue Xue Bao 2012 43 3 297 300
42. Li C. J., Experimental Research of Wuling Powder on Metabolic Hypertension 2008 Jilin, China Changchun University of Chinese Medical
43. Higgins J. P. T., Green S., Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [Updated March 2011] 2009 Oxford, UK The Cochrane Collaboration
44. Ke B., Shi L., Zhang J. J., Meng J., Chen D. S., Qin J., Clinical research of modified Fuling Guizhi Baizhu Gancao decoction combined with short-term fasting on obesity-related hypertension. Zhongguo Zhong Yi Yao Ke Ji 2012 19 5 399 400
45. Quan Y. H., Lei X. J., Influence of supplemented Liujunzi decoction on serum leptin in patients with obesity-related hypertension. Nanjing Zhong Yi Yao Da Xue Xue Bao 2011 27 2 181 183
46. Lian D. H., Effect of modified Wendan decoction on 60 cases of obesity-related hypertension patients with phlegm and dampness syndrome. Henan Zhong Yi 2012 32 7 913 914
47. Wang C., Yang Y., Cheng Z., Improvements of Pinggan Yishen Ditan Yin in blood pressure, body weight and quality of life in patients with obesity hypertension. Chinese Journal of Clinical Rehabilitation 2006 10 43 24 26 2-s2.0-33846059321
48. Hu M. Q., Cui W. N., Xu Y. L., Influence of Naoxintong capsule on serum leptin in patients with obesity-related hypertension. Renmin Jun Yi 2011 54 1 36 37
49. Gao Z. Y., Treatment of patients with obesity and hypertension by calming liver, expelling phlegm and removing blood stasis. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 2007 5 8 679 680
50. Zhang Y. H., Lu F. E., Li J. L., Wang W., Li M. L., Effect of Qingre huoxue qutan decoction on insulin resistance in patients with obesity-related hypertension. Zhong Yi Za Zhi 2003 44 10 747 749
51. Zheng L. H., The Antihypertensive Effect and Influence of Insulin Resistance of Shugan Yunpi in Obesity and Hypertension 2012 Shandong, China Shandong University of Chinese Medical
52. Liu Y. J., Effect of Taohong erchen tianma decoction on insulin resistance in patients with obesity-related hypertension. Zhongguo Zhong Yi Yao Ke Ji 2006 13 6 432 433
53. He S. Z., Treatment of Obesity Hypertension Clinical Research and the Effect on Leptin Resistance by Traditional Chinese Medicine Which Activating Blood and Expelling Phlegm 2008 Guangdong, China Guangzhou University of Chinese Medical
54. Chen Y., Xu L. H., Clinical observation of 60 cases of patients with obesity-related hypertension treated by integrative medicine. Jiangsu Zhong Yi Yao 2008 40 6 36 37
55. Xu H., Chen K., Herb-drug interaction: an emerging issue of integrative medicine. Chinese Journal of Integrative Medicine 2010 16 3 195 196 2-s2.0-78149421985 10.1007/s11655-010-0195-z
56. Xiong X. J., Wang J., He Q. Y., Thinking about reducing adverse reactions based on idea of formula corresponding to syndromes. Zhongguo Zhongyao Zazhi 2010 35 4 536 538 2-s2.0-77952229521 10.4268/cjcmm20100429
57. Wang J., Xiong X. J., Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 697237 10.1155/2012/697237